Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-15
2007-05-15
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S400000
Reexamination Certificate
active
10869038
ABSTRACT:
ACE inhibitor nitroderivatives of formula (I):in-line-formulae description="In-line Formulae" end="lead"?A—(X1—ONO2)s (I)in-line-formulae description="In-line Formulae" end="tail"?having wider pharmacological activity and enhanced tolerability. They can be employed for treating cardiovascular and renal diseases and inflammatory processes.
REFERENCES:
patent: 4574079 (1986-03-01), Gavras et al.
patent: 6242432 (2001-06-01), del Soldato
patent: 97/16405 (1997-05-01), None
patent: 98/21193 (1998-05-01), None
patent: WO 98/21193 (1998-05-01), None
patent: WO 00/61537 (2000-10-01), None
patent: WO 00/61541 (2000-10-01), None
patent: WO 01/12584 (2001-02-01), None
Olson et al., “Altered Glomerular Permselectivity and Progression Sclerosis Following Extreme Ablation of Renal Mass,”Kidney International22 112-126, 1982.
Schroth et al., “Strong Distortion of the Tetrahedral Geometry in a Spirosilicate: Molecular Structure of Bis(tetramethylethylenedioxy)silane,”Angew. Chem. Int. Ed. Engl.22 65-66, 1983.
Kubota et al., “Studies on Angiotensin Converting Enzyme Inhibitors. V.1)The Diasteroselective 2-Oxoimidazolidine Derivatives2),”Chem. Pharm. Bull.39 1374-1377, 1991.
Wanstall et al., “Vascular Smooth Muscle Relaxation Mediated by Nitric Oxide Donors: A Comparison With Acetylcholine, Nitric Oxide and Nitroxyl Ion,”British Journal of Pharmacology134 463-472, 2001.
Iwanaga et al., “A Nitric Oxide-Releasing Derivative of Enalapril, NCX 899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopatic Hamsters with Heart Failure,”AHA75, 2002.
Iwanaga et al., “A Nitric Oxide-Releasing Derivative of Enalapril, NCX 899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopatic Hamsters with Heart Failure,”The FASEB Journal,2004.
Sweetman et al., “Martindale The Complete Drug Reference,”Pharmaceutical Press.
Almirante Nicoletta
Del Soldato Piero
Ongini Ennio
Arent & Fox LLP
Chung Susannah L.
Nicox S.A.
Saeed Kamal A.
LandOfFree
ACE inhibitor derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ACE inhibitor derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ACE inhibitor derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3734554